2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T46bd,

Summary Table

Domain	Detail
Risk Factors	Chronic alcoholism, malnutrition, strict veganism without supplementation, malabsorption syndromes (celiac disease, Crohn disease), elderly with poor dietary intake, prolonged use of phenobarbital or oral contraceptives, phototherapy in neonates
Etiology	Inadequate dietary intake of riboflavin (vitamin B2), which serves as the precursor to the coenzymes flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN)
Patient Presentation	Sore throat, painful cracks at the corners of the mouth, swollen tongue, skin changes around the nose and mouth
Classic Physical Exam	Angular cheilitis (fissures at the oral commissures), magenta-colored glossitis, seborrheic dermatitis concentrated at the nasolabial folds and scrotum/vulva, corneal vascularization
Key Diagnostic Results	Decreased erythrocyte glutathione reductase activity coefficient (EGRAC) elevated above 1.4, low urinary riboflavin excretion (<40 mcg/day), normocytic normochromic anemia
Management	Oral riboflavin supplementation (5 to 30 mg/day), dietary counseling, treat coexisting B-vitamin deficiencies
Keywords	"Cracks at corners of the mouth," "magenta tongue," "corneal neovascularization," "FAD/FMN," "oro-oculo-genital syndrome"

1. Pathophysiology

Riboflavin is a water-soluble vitamin absorbed primarily in the proximal small intestine. Once absorbed, it is phosphorylated intracellularly to form FMN (by flavokinase) and subsequently converted to FAD (by FAD synthetase). These two coenzymes are essential for a wide range of oxidation-reduction reactions throughout the body, including the electron transport chain (complexes I and II), fatty acid beta-oxidation, and the conversion of other B vitamins into their active forms.

FAD is required for the activity of methylenetetrahydrofolate reductase (MTHFR), which links riboflavin to folate metabolism. It is also required for the conversion of pyridoxine (B6) to its active coenzyme form, pyridoxal phosphate (PLP). This is why riboflavin deficiency rarely occurs in isolation and frequently presents alongside deficiencies of folate, niacin (B3), and pyridoxine (B6). This interdependence is a frequently tested concept.

The mucocutaneous signs of ariboflavinosis arise because rapidly dividing epithelial tissues are highly dependent on FAD/FMN-driven energy metabolism. When these coenzymes are deficient, epithelial turnover at the oral commissures, tongue surface, and skin folds is impaired, leading to angular cheilitis, glossitis, and seborrheic-like dermatitis. The corneal vascularization occurs because riboflavin is critical for maintaining corneal avascularity through its role in antioxidant defense (FAD is a cofactor for glutathione reductase, which regenerates reduced glutathione). Without adequate glutathione cycling, oxidative damage triggers neovascularization of the cornea.

The anemia seen in riboflavin deficiency is typically normocytic and normochromic, resulting from impaired iron mobilization and utilization (FAD is required for ferritin iron release). However, because riboflavin deficiency impairs folate metabolism via MTHFR, a secondary megaloblastic component can develop if folate status is borderline.

2. Classification and Clinical Manifestation

System	Clinical Manifestation	Mechanism
Oral	Angular cheilitis (bilateral fissures at oral commissures), magenta glossitis (swollen, smooth, purple-red tongue), cheilosis (cracked/peeling lips)	Impaired epithelial cell turnover at mucocutaneous junctions
Ocular	Photophobia, burning/itching of eyes, corneal vascularization (superficial neovascularization), interstitial keratitis	Loss of glutathione-mediated antioxidant protection in the cornea
Dermatologic	Seborrheic dermatitis at the nasolabial folds, ears, and eyelids; scrotal/vulvar dermatitis (erythematous, scaly, pruritic)	FAD-dependent lipid metabolism failure in sebaceous gland-rich skin
Hematologic	Normocytic normochromic anemia, possible reticulocytopenia	Impaired iron mobilization from ferritin stores; secondary folate pathway dysfunction
Neurologic	Peripheral neuropathy (rare, typically only in severe or prolonged deficiency)	Disrupted myelin maintenance due to impaired fatty acid oxidation

A key teaching point: the magenta or purplish hue of the tongue is what distinguishes riboflavin-related glossitis from the beefy red glossitis of B12/folate deficiency and the raw, scarlet glossitis of niacin deficiency (pellagra). This color distinction is a reliable discriminator in vignettes.

3. Diagnostic Workup

Test	Role	Expected Finding
Erythrocyte glutathione reductase activity coefficient (EGRAC)	Most accurate / confirmatory	EGRAC > 1.4 indicates deficiency (measures FAD-dependent enzyme saturation)
Urinary riboflavin excretion (24-hour)	Supportive / screening	< 40 mcg/day (reflects recent intake rather than tissue stores)
Serum riboflavin level	Supportive	Low, but not reliable in isolation due to fluctuation with recent meals
CBC with peripheral smear	Assess hematologic impact	Normocytic normochromic anemia; rule out megaloblastic changes
Additional B-vitamin panel (folate, B6, B12, niacin metabolites)	Identify coexisting deficiencies	Often reveals concurrent low levels due to metabolic interdependence

The best initial test in clinical practice is often the clinical diagnosis itself, as the triad of angular cheilitis, glossitis, and dermatitis in a malnourished or alcoholic patient is strongly suggestive. However, when biochemical confirmation is needed, the EGRAC is the most reliable functional assay. It works by measuring the activity of glutathione reductase in red blood cells before and after the addition of exogenous FAD in vitro. If the enzyme activity increases substantially after FAD is added (coefficient > 1.4), it proves the enzyme was undersaturated with its cofactor, confirming tissue-level riboflavin deficiency.

Urinary riboflavin reflects short-term intake and drops quickly with inadequate diet, making it useful as a population-level screening tool but less reliable for individual diagnosis.

Because riboflavin deficiency impairs the metabolism of folate, B6, and niacin, a complete B-vitamin assessment should be ordered. Exam vignettes may present a patient who appears to have pellagra or B6 deficiency but fails to respond to targeted supplementation, and the "next best step" is to check riboflavin status and supplement accordingly.

4. Management and Treatment

Setting	Intervention	Details
Mild deficiency (dietary)	Oral riboflavin	5 to 10 mg/day until symptoms resolve (typically 2 to 6 weeks)
Moderate to severe deficiency	Oral riboflavin	10 to 30 mg/day in divided doses
Malabsorption or critical illness	Consider parenteral multivitamin formulation	Riboflavin included in standard IV multivitamin preparations
All patients	Dietary counseling	Increase dairy products, eggs, lean meats, green leafy vegetables, fortified cereals
Coexisting deficiencies	Concurrent supplementation	Folate, B6, B12, and/or niacin as indicated by lab results

Oral supplementation is the mainstay of treatment. Riboflavin is well absorbed even in moderate malabsorption states because absorption occurs via a saturable, carrier-mediated transport system in the proximal jejunum. Doses above approximately 25 to 30 mg are absorbed with diminishing efficiency, so dividing larger doses (e.g., 10 mg three times daily rather than 30 mg once daily) improves bioavailability.

Clinical improvement is usually rapid. Angular cheilitis and glossitis begin improving within days to one to two weeks, while corneal vascularization may take longer to regress. Patients should be counseled that their urine may turn bright yellow/fluorescent during supplementation, which is a harmless sign of riboflavin excretion and not a cause for concern.

An important management pearl: if a patient with suspected pellagra (niacin deficiency) does not improve with niacin supplementation alone, consider underlying riboflavin deficiency. FAD is required for the tryptophan-to-niacin conversion pathway (the enzyme kynurenine 3-monooxygenase is FAD-dependent), so riboflavin deficiency can functionally cause secondary niacin deficiency. The "next best step" in a niacin-refractory pellagra case is to add riboflavin.

There are no notable drug contraindications to riboflavin supplementation. It is safe in pregnancy and in patients with renal or hepatic impairment. Excess riboflavin is efficiently excreted in urine, making toxicity essentially nonexistent.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Looks Similar	Key Discriminator
Iron deficiency	Also causes angular cheilitis and glossitis	Iron deficiency produces a pale, smooth tongue (not magenta); associated with microcytic anemia, koilonychia, and pica; no corneal or genital findings
Vitamin B3 (Niacin) deficiency / Pellagra	Glossitis, dermatitis, mucosal inflammation	Pellagra has the classic "3 Ds" (dermatitis, diarrhea, dementia); the dermatitis is photosensitive and in sun-exposed areas (Casal necklace), not at skin folds; glossitis is beefy red, not magenta
Vitamin B6 (Pyridoxine) deficiency	Angular cheilitis, glossitis, seborrheic dermatitis	B6 deficiency is more strongly associated with peripheral neuropathy, seizures (especially in infants), and sideroblastic anemia (ringed sideroblasts on bone marrow); no corneal vascularization
Vitamin B12 deficiency	Glossitis, anemia	B12 produces a beefy red, smooth tongue (Hunter glossitis), megaloblastic anemia with hypersegmented neutrophils, and prominent neuropsychiatric symptoms (subacute combined degeneration); no angular cheilitis or genital dermatitis
Zinc deficiency	Perioral dermatitis, angular cheilitis	Zinc deficiency (acrodermatitis enteropathica) shows acral and periorificial vesiculobullous/erosive dermatitis, alopecia, diarrhea; no glossitis color change or corneal findings
Oral candidiasis (angular form)	Fissures at the oral commissures	Usually unilateral or asymmetric, with white plaques; responds to antifungals; KOH prep shows pseudohyphae; no glossitis or dermatitis

6. Traps and High-Yield Pearls

The most common way students miss riboflavin deficiency questions is by anchoring on a single mucocutaneous finding (like angular cheilitis or glossitis) and jumping to iron deficiency or B12 deficiency without considering the full clinical picture. The exam tests whether you can recognize the combination of oral, ocular, and genital findings as a unified syndrome rather than isolated problems.

A second frequent trap involves the interdependence of B vitamins. A vignette may describe a malnourished patient treated for pellagra or B6 deficiency who fails to improve. The expected next step is not to increase the dose of the current supplement but to add riboflavin, because FAD is upstream of both the niacin synthesis pathway and the B6 activation pathway. Students who do not understand this metabolic relationship will miss the question.

The magenta tongue is the single most reliable vignette cue. While many B-vitamin deficiencies cause glossitis, the purplish-magenta color is distinctive to riboflavin deficiency, as opposed to the beefy red tongue of B12/folate deficiency or the scarlet tongue of pellagra. If a question stem uses the word "magenta" in any context, riboflavin should immediately be at the top of your differential.

Finally, remember that corneal vascularization in the context of nutritional deficiency points almost exclusively to riboflavin. This finding is uncommon in other vitamin deficiencies and serves as a strong discriminator when the oral findings are ambiguous.

The core competency being tested is the ability to (1) recognize the oro-oculo-genital triad, (2) understand the metabolic role of FAD/FMN as upstream cofactors for other B-vitamin pathways, and (3) identify riboflavin deficiency as the underlying cause when targeted B-vitamin supplementation for another deficiency fails to produce clinical improvement.

1e:["$","$L2d",null,{"article":{"id":"2c6e39ab-a343-4a10-b7d8-dfc95cf71a52","title":"Defisiensi Vitamin B2","content":"$2e","category":"Endokrin-Metabolik","created_at":"2026-05-17T02:34:28.919858+00:00","status":"published","subcategory":null},"questionCount":0,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]